Synthesis, characterization and evaluation of hyaluronic acid-based polymers for nasal delivery.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
25 Jan 2023
Historique:
received: 07 09 2022
revised: 29 11 2022
accepted: 12 12 2022
pubmed: 19 12 2022
medline: 14 1 2023
entrez: 18 12 2022
Statut: ppublish

Résumé

Epidemiological research has found that between 5 and 12 percent of the population suffers from chronic rhinosinusitis. Patients are dealing with local side effects such as nasal dryness, sporadic sneezing, and nasal pain in addition to the inflammation. The aim of this study was to synthesize a polymer based on hyaluronic acid in order to provide lubrication combined with a ligand leading to a covalent binding on the nasal mucosa. Hyaluronic acid (HA) was modified with L-cysteine ethyl ester hydrochloride (CYS) via amid bond formation. Ellman's assay, together with spectroscopic techniques like IR and

Identifiants

pubmed: 36529356
pii: S0378-5173(22)01051-1
doi: 10.1016/j.ijpharm.2022.122496
pii:
doi:

Substances chimiques

Hyaluronic Acid 9004-61-9
Polymers 0
Sulfhydryl Compounds 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122496

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Auteurs

Flavia Laffleur (F)

Department of Pharmaceutical Technology, University of Innsbruck, Institute of Pharmacy, Innrain 80-82, 6020 Innsbruck, Austria. Electronic address: Flavia.Laffleur@uibk.ac.at.

Nikolas Hörmann (N)

Department of Pharmaceutical Chemistry, University of Innsbruck, Institute of Pharmacy, Innrain 80-82, 6020 Innsbruck, Austria.

Ronald Gust (R)

Department of Pharmaceutical Chemistry, University of Innsbruck, Institute of Pharmacy, Innrain 80-82, 6020 Innsbruck, Austria.

Ariane Ganner (A)

Department of Pharmaceutical Technology, University of Innsbruck, Institute of Pharmacy, Innrain 80-82, 6020 Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH